This information was published on 2025-08-20T00:09:18 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2540667 (IR 1850475) |
| (220) |
19 Mar 2025
|
| (511) (510) |
Class 5
Pharmaceutical product and therapeutic pharmaceutical product for Netherton Syndrome, and rare and orphan diseases. Class 42 Pharmaceutical development of therapeutic pharmaceuticals for the treatment of diseases. |
| (540) | QELTIQ |
| (550) | Word |
| (730) |
Quoin Pharmaceuticals, Inc.
|
Find out more about publications on the About page.